The in vitro effects of stem cell factor, interleukin 3 and granulocyte‐macrophage colony stimulating factor on haemopoietic progenitor cells from premature infants

No abstract is available for this paper.

• Publication year

  1994

• Venue

  British Journal of Haematology

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.1994.tb04775.xPMID 7519035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: physiologic implications.

  1993cited by this paper
• Double blind trial of recombinant human erythropoietin in preterm infants.

  1993cited by this paper
• Erythropoietin affects the maturation pattern of fetal G‐CSF‐responsive progenitors

  1992cited by this paper
• The in vitro effect of high‐dose recombinant human erythropoietin on granulocyte‐macrophage colony production in premature infants using a defined serum deprived cell culture system

  1992cited by this paper
• Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.

  1992cited by this paper
• Administration of erythropoietin to newborn rats results in diminished neutrophil production.

  1991cited by this paper
• Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro

  1991cited by this paper
• Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.

  1991cited by this paper
• Human burst-forming units-erythroid need direct interaction with stem cell factor for further development.

  1991cited by this paper
• Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

  1991cited by this paper
• Erythropoietic progenitor cells from premature neonates studied using a validated serum-deprived medium

  1991cited by this paper
• Erythropoietin responsive progenitors in anaemia of prematurity.

  1991cited by this paper
• Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

  1991cited by this paper
• High gradient magnetic cell separation with MACS.

  1990cited by this paper
• Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

  1990cited by this paper
• Down-modulation of neutrophil production by erythropoietin in human hematopoietic clones.

  1989cited by this paper
• Down-modulation of neutrophil production by erythropoietin in human hematopoietic clones

  1989cited by this paper
• Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity".

  1988cited by this paper
• Cloning of human erythroid progenitors (BFU‐E) in the absence of fetal bovine serum

  1987cited by this paper
• Circulating erythroid progenitors in the anemia of prematurity.

  1987cited by this paper
• Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin.

  1985cited by this paper
• Interleukin 3 promotes erythroid burst formation in "serum-free" cultures without detectable erythropoietin.

  1985cited by this paper
• Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity.

  1984cited by this paper
• Anemia of prematurity: determinants of the erythropoietin response.

  1984cited by this paper
• Posttransfusion Cytomegalovirus Infections

  1982cited by this paper
• Effect of modulators of erythropoiesis on the hemoglobinization of human erythroid cell cultures

  1982cited by this paper
• Effect of modulators of erythropoiesis on the hemoglobinization of human erythroid cell cultures.

  1982cited by this paper
• Posttransfusion cytomegalovirus infections.

  1982cited by this paper
• Anemia of prematurity.

  1981cited by this paper
• Competition between erythropoietin and colony-stimulating factor for target cells in mouse marrow.

  1979cited by this paper
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood.

  1978cited by this paper
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood

  1978cited by this paper
• Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses.

  1977cited by this paper
• The anemia of prematurity. Factors governing the erythropoietin response.

  1977cited by this paper
• Normal Human Bone Marrow Cultures in Vitro: Cellular Composition and Maturation of the Granulocytic Colonies

  1977cited by this paper
• ENHANCED ERYTHROPOIESIS WITH CONCOMITANT DIMINISHED GRANULOPOIESIS IN PREIRRADIATED RECIPIENT MICE

  1968cited by this paper
• Colony Production in vitro by Normal Polycythaemic and Anaemic Bone Marrow

  1967cited by this paper
• Haematopoietic Stem Cells: Evidence for Competing Proliferative Demands

  1967cited by this paper

• Nutrition , Anaemia and Erythropoietin Therapy lain

  2016cites this paper
• Hematopoietic Stem Cells for Transplantation Placental and/or Umbilical Cord Blood: An Alternative Source of

  2014cites this paper
• SPARC promotes the development of erythroid progenitors.

  2012cites this paper
• A Randomized, Controlled Trial of Prophylactic Granulocyte-Macrophage Colony-Stimulating Factor in Human Newborns Less Than 32 Weeks Gestation

  1999cites this paper
• Is there a role for adjuvant therapy in patients being treated with epoetin?

  1999cites this paper
• Filgrastim for treatment of neutropenia in a neonate.

  1999cites this paper
• Metabolic Adjuvants to Erythropoietin Therapy

  1999cites this paper
• Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation.

  1997cites this paper
• Haemopoietic colony stimulating factors for preterm neonates

  1997cites this paper
• Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential.

  1997cites this paper
• Umbilical vein endothelial cells are an important source of c‐kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells

  1996cites this paper
• Ex vivo expansion of haemopoietic progenitor cells.

  1996cites this paper
• The effect of mast cell growth factor on peripheral blood granulocyte‐macrophage colony‐forming cells in methylcellulose in myeloproliferative disorders

  1995cites this paper
• Haemopoietic colony‐forming cells from peripheral blood stem cells harvests: cytokine requirements and lineage potential

  1994cites this paper